Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 09:12 am Sale | 13G | BIOTECH ACQUISITION CO USD CL BIOT | Radcliffe Capital Management L.P. | 0 0% | -405,900 (Position Closed) | View |
| 2023-02-14 10:50 am Unchanged | 13G | BIOTECH ACQUISITION CO USD CL BIOT | GOLDMAN SACHS GROUP INC GS | 250,525 1.1% | 0 (Unchanged) | View |
| 2023-02-14 10:35 am Purchase | 13G | BIOTECH ACQUISITION CO USD CL BIOT | GLAZER CAPITAL LLC | 2,283,910 9.93% | 2,283,910 (New Position) | View |
| 2023-02-13 3:47 pm Sale | 13G | BIOTECH ACQUISITION CO USD CL BIOT | Beryl Capital Management LLC | 0 0% | -2,039,377 (Position Closed) | View |
| 2023-02-13 2:11 pm Purchase | 13G | BIOTECH ACQUISITION CO USD CL BIOT | ARISTEIA CAPITAL L.L.C. | 1,524,010 6.63% | 375,000 (+32.64%) | View |
| 2023-01-27 1:18 pm Purchase | 13G | BIOTECH ACQUISITION CO USD CL BIOT | Radcliffe Capital Management L.P. | 405,900 5.39% | 405,900 (New Position) | View |
| 2023-01-25 12:12 pm Purchase | 13G | BIOTECH ACQUISITION CO USD CL BIOT | Hudson Bay Capital Management LP | 1,261,609 5.49% | 1,261,609 (New Position) | View |
| 2022-05-16 4:37 pm Purchase | 13G | BIOTECH ACQUISITION CO USD CL BIOT | Beryl Capital Management LLC | 2,039,377 8.9% | 2,039,377 (New Position) | View |
| 2022-02-14 4:01 pm Purchase | 13G | BIOTECH ACQUISITION CO USD CL BIOT | Biotech Sponsor LLC | 5,750,000 20% | 5,750,000 (New Position) | View |
| 2022-02-14 2:08 pm Sale | 13G | BIOTECH ACQUISITION CO USD UNT BIOTU | Atalaya Capital Management LP | 928,125 4% | -556,875 (-37.50%) | View |
| 2022-02-14 08:44 am Purchase | 13G | BIOTECH ACQUISITION CO USD CL BIOT | ARISTEIA CAPITAL L.L.C. | 1,149,010 5% | 1,149,010 (New Position) | View |
| 2022-02-10 12:29 pm Purchase | 13G | BIOTECH ACQUISITION CO USD CL BIOT | GOLDMAN SACHS GROUP INC GS | 1,194,678 5.2% | 1,194,678 (New Position) | View |
| 2021-12-14 4:22 pm Unchanged | 13G | BIOTECH ACQUISITION CO USD UNT BIOTU | Atalaya Capital Management LP | 1,485,000 6.5% | 0 (Unchanged) | View |
| 2021-02-16 5:07 pm Purchase | 13G | BIOTECH ACQUISITION CO USD UNT BIOTU | Vellar Opportunities Fund Master Ltd. | 1,500,000 6.5% | 1,500,000 (New Position) | View |
| 2021-02-05 4:26 pm Purchase | 13G | BIOTECH ACQUISITION CO USD UNT BIOTU | Atalaya Capital Management LP | 1,485,000 6.5% | 1,485,000 (New Position) | View |